Form 4: ICU Medical CEO Vivek Jain Exercises Options and Sells Shares Under 10b5-1 Plan

ICU Medical's Chairman and CEO, Vivek Jain, executed stock options and sold shares of common stock on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 3, 2024, Vivek Jain, Chairman and CEO of ICU Medical Inc., exercised non-qualified stock options to acquire common stock at a price of $88.76 per share.
• Concurrently, Jain sold these shares on the same day at weighted average prices ranging from $162.694 to $164.0731.
• These transactions were executed under a previously established Rule 10b5-1 trading plan adopted on March 15, 2024.
• The total number of shares sold was 12,000, resulting in a remaining direct ownership of 104,593 shares and indirect ownership of 88,698 shares held by a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document simply reports transactions executed under a pre-existing plan. There is no indication of positive or negative implications for the company's performance.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating a planned and orderly approach to stock sales.

Industry Context

Executive stock option exercises and sales are common in publicly traded companies and are often governed by Rule 10b5-1 plans to avoid insider trading concerns. The disclosure provides transparency into executive compensation and trading activities.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.

Key Dates